Northern Trust
ANVS icon

Northern Trust’s Annovis Bio ANVS Stock Holding History

Northern Trust’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$316K Buy
141,730
+20,868
+17% +$57.2K ﹤0.01% 3785
2025
Q4 		$418K Sell
120,862
-198
-0.2% -$595 ﹤0.01% 3721
2025
Q3 		$251K Buy
121,060
+61,546
+103% +$154K ﹤0.01% 3902
2025
Q2 		$129K Buy
59,514
+18,835
+46% +$37.2K ﹤0.01% 4053
2025
Q1 		$61K Buy
40,679
+7,899
+24% +$24.2K ﹤0.01% 4202
2024
Q4 		$165K Buy
32,780
+10,846
+49% +$78.5K ﹤0.01% 4041
2024
Q3 		$177K Buy
21,934
+2,699
+14% +$25.3K ﹤0.01% 3917
2024
Q2 		$111K Sell
19,235
-5,032
-21% -$40.8K ﹤0.01% 4024
2024
Q1 		$289K Sell
24,267
-4,781
-16% -$52.2K ﹤0.01% 3758
2023
Q4 		$543K Buy
29,048
+18,868
+185% +$167K ﹤0.01% 3512
2023
Q3 		$96.6K Hold
10,180
– – ﹤0.01% 4023
2023
Q2 		$145K Buy
+10,180
New +$144K ﹤0.01% 3937
2021
Q4 		– Sell
-9,098
Closed -$289K – 4772
2021
Q3 		$289K Hold
9,098
– – ﹤0.01% 4002
2021
Q2 		$779K Buy
9,098
+1,673
+23% +$77.3K ﹤0.01% 3593
2021
Q1 		$207K Buy
+7,425
New +$159K ﹤0.01% 4106

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust's ANVS Position: Q1 2026 in Review

Northern Trust increased its Annovis Bio (ANVS) stake by 17% in Q1 2026, buying an estimated $57.2K and bringing the position to 141,730 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #3785.

Northern Trust first reported a position in ANVS in Q1 2021 and has held it in 15 quarters since. The position peaked at $779K in Q2 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Northern Trust held 141,730 shares of Annovis Bio worth $316K as of Q1 2026.
  • Northern Trust bought 20,868 Annovis Bio shares in Q1 2026, an estimated $57.2K.
  • Annovis Bio made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3785 holding.
  • Northern Trust first reported a position in Annovis Bio in Q1 2021 and has held it in 15 quarters since.
  • Northern Trust's Annovis Bio position peaked at $779K in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.